Page last updated: 2024-11-13

nicotinate mononucleotide

Description Research Excerpts Clinical Trials Roles Classes Pathways Study Profile Bioassays Related Drugs Related Conditions Protein Interactions Research Growth Market Indicators

Description

nicotinate D-ribonucleotide(2-) : Dianion of nicotinic acid D-ribonucleotide arising from deprotonation of carboxylic acid and phosphate functions. [Chemical Entities of Biological Interest (ChEBI), Hastings J, Owen G, Dekker A, Ennis M, Kale N, Muthukrishnan V, Turner S, Swainston N, Mendes P, Steinbeck C. (2016). ChEBI in 2016: Improved services and an expanding collection of metabolites. Nucleic Acids Res]

Cross-References

ID SourceID
PubMed CID46878382
CHEBI ID57502
MeSH IDM0043806

Synonyms (20)

Synonym
nicotinate-d-ribonucleotide
deamido-nicotinamide mononucleotide
namn
nicotinic acid mononucleotide
nicotinate mononucleotide
nicotinic acid nucleotide
deamido-nmn
321-02-8
nicotinate nucleotide
beta-nicotinate d-ribonucleotide
nicotinate dinucleotide
beta-nicotinate-d-nucleotide
nicotinic acid ribonucleotide
nicotinate d-ribonucleotide dianion
nicotinate beta-d-ribonucleotide
CHEBI:57502
nicotinate d-ribonucleotide(2-)
1-(5-o-phosphonato-beta-d-ribofuranosyl)pyridinium-3-carboxylate
3-carboxylato-1-(5-o-phosphonato-beta-d-ribofuranosyl)pyridinium
Q27124739
[information is derived through text-mining from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Roles (2)

RoleDescription
human metaboliteAny mammalian metabolite produced during a metabolic reaction in humans (Homo sapiens).
Saccharomyces cerevisiae metaboliteAny fungal metabolite produced during a metabolic reaction in Baker's yeast (Saccharomyces cerevisiae).
[role information is derived from Chemical Entities of Biological Interest (ChEBI), Hastings J, Owen G, Dekker A, Ennis M, Kale N, Muthukrishnan V, Turner S, Swainston N, Mendes P, Steinbeck C. (2016). ChEBI in 2016: Improved services and an expanding collection of metabolites. Nucleic Acids Res]

Drug Classes (1)

ClassDescription
organophosphate oxoanionAn organic phosphoric acid derivative in which one or more oxygen atoms of the phosphate group(s) has been deprotonated.
[compound class information is derived from Chemical Entities of Biological Interest (ChEBI), Hastings J, Owen G, Dekker A, Ennis M, Kale N, Muthukrishnan V, Turner S, Swainston N, Mendes P, Steinbeck C. (2016). ChEBI in 2016: Improved services and an expanding collection of metabolites. Nucleic Acids Res]

Pathways (31)

PathwayProteinsCompounds
NAD salvage pathway II (PNC IV cycle)012
nicotine biosynthesis221
NAD biosynthesis from 2-amino-3-carboxymuconate semialdehyde014
NAD de novo biosynthesis I (from aspartate)522
NAD de novo biosynthesis II (from tryptophan)024
superpathway of nicotine biosynthesis229
pyridine nucleotide cycling (plants)322
NAD salvage pathway V (PNC V cycle)017
Renz2020 - GEM of Human alveolar macrophage with SARS-CoV-20490
16p11.2 proximal deletion syndrome039
NAD de novo biosynthesis1233
superpathway of tryptophan utilization4292
nicotine biosynthesis224
pyridine nucleotide cycling (plants)022
superpathway of nicotine biosynthesis232
5-methoxybenzimidazolyl adenosylcobamide biosynthesis from adenosylcobinamide-GDP29
adeninyl adenosylcobamide biosynthesis from adenosylcobinamide-GDP310
adenosylcobalamin biosynthesis from adenosylcobinamide-GDP I512
5-methylbenzimidazolyl adenosylcobamide biosynthesis from adenosylcobinamide-GDP38
2-methyladeninyl adenosylcobamide biosynthesis from adenosylcobinamide-GDP38
phenyl adenosylcobamide biosynthesis from adenosylcobinamide-GDP39
5-hydroxybenzimidazolyl adenosylcobamide biosynthesis from adenosylcobinamide-GDP38
5-methoxy-6-methylbenzimidazolyl adenosylcobamide biosynthesis from adenosylcobinamide-GDP28
4-methylphenyl adenosylcobamide biosynthesis from adenosylcobinamide-GDP69
benzimidazolyl adenosylcobamide biosynthesis from adenosylcobinamide-GDP38
aspartate superpathway25122
NAD salvage pathway I (PNC VI cycle)420
NAD salvage pathway II (PNC IV cycle)314
NAD de novo biosynthesis II (from tryptophan)1835
NAD de novo biosynthesis I (from aspartate)734
superpathway of NAD biosynthesis in eukaryotes1135
NAD salvage pathway V (PNC V cycle)421
NAD biosynthesis from 2-amino-3-carboxymuconate semialdehyde816
nicotinate riboside salvage pathway I15
NAD salvage pathway1121
adenosylcobalamin biosynthesis from cobyrinate a,c-diamide I626
adenosylcobalamin salvage from cobinamide I419
adenosylcobalamin biosynthesis II (aerobic)060
adenosylcobalamin biosynthesis II (late cobalt incorporation)2655

Research

Studies (51)

TimeframeStudies, This Drug (%)All Drugs %
pre-199015 (29.41)18.7374
1990's10 (19.61)18.2507
2000's10 (19.61)29.6817
2010's15 (29.41)24.3611
2020's1 (1.96)2.80
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Market Indicators

Research Demand Index: 19.94

According to the monthly volume, diversity, and competition of internet searches for this compound, as well the volume and growth of publications, there is estimated to be moderate demand-to-supply ratio for research on this compound.

MetricThis Compound (vs All)
Research Demand Index19.94 (24.57)
Research Supply Index3.95 (2.92)
Research Growth Index4.59 (4.65)
Search Engine Demand Index18.60 (26.88)
Search Engine Supply Index2.00 (0.95)

This Compound (19.94)

All Compounds (24.57)

Study Types

Publication TypeThis drug (%)All Drugs (%)
Trials0 (0.00%)5.53%
Reviews1 (1.96%)6.00%
Case Studies0 (0.00%)4.05%
Observational0 (0.00%)0.25%
Other50 (98.04%)84.16%
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]